Argentina to set up radiopharma and bioproducts evaluations centre
This article was originally published in Clinica
The Argentine health ministry is to establish a radiopharmaceuticals and bioproducts evaluations centre, as part of a programme to modernise national healthcare regulatory agency ANMAT. The initiative was approved last week with the signing of a memorandum of understanding with the World Bank, which is providing US$4.5m. Other plans outlined in a health ministry statement on the programme include: better monitoring, through "fiscalisation measures", of the quality standards of healthcare products; and developing the agency's R&D activities.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.